ARTICLE | Company News
Icos, Seattle Genetics deal
August 20, 2001 7:00 AM UTC
ICOS will provide process development, scale-up and GMP manufacturing for the monoclonal antibody component of SGEN's SGN-15. SGN-15 is a monoclonal antibody chemically linked to doxorubicin and is in...